Algernon Logo 1.png
Algernon Pharmaceuticals Announces Small Cell Lung Cancer Ifenprodil Research Program and Appoints Dr. William North as Lead Consultant
11. August 2021 07:00 ET | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
Algernon Logo 1.png
Algernon Pharmaceuticals Announces Exclusive Licensing Agreement with Dartmouth College
09. August 2021 07:00 ET | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
1555102157573_5c7ea78883c747000486abc8_logo.jpg
Qrons Extends Sponsored Research Agreement with Dartmouth College
11. November 2019 08:00 ET | Qrons Inc.
Supports Continued Research for the Development of Innovative 3D Printable, Biocompatible Advanced Materials, and Stem Cell Delivery Techniques for Traumatic Brain Injuries  NEW YORK, NY, Nov. 11,...
External Remote Pati
External Remote Patient Monitoring Devices Market Well Prepared To Meet Futuristic Demands Of Healthcare At Home - MarketIntelReports
26. März 2017 11:30 ET | Market Intel Reports LLP
Wilmington, Delaware, United States, March 26, 2017 (GLOBE NEWSWIRE) -- The report “External Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2016”, available on...